-
Symbol
-
SAGE
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
-
Latest Disclosed Shares Owned
-
0 shares
-
Security Ownership %
-
0%
Biogen Inc. ownership in Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)
30 Jul 2025 - Biogen Inc. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE).
This represents 0% ownership of the company.
In their previous filing dated 21 Jul 2025, BIOGEN INC. had reported owning 6,241,473 shares, indicating a decrease of +100%.
.